Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Blake Buzard"'
Autor:
Lara Kujtan, Rama Krishna Kancha, Beth Gustafson, Lindsey Douglass, Christopher RH Ward, Blake Buzard, Janakiraman Subramanian
Publikováno v:
Expert Review of Anticancer Therapy. 22:203-213
Immune checkpoint inhibitors (ICIs) have revolutionized treatment for patients with non-small lung cancer (NSCLC). Currently approved ICIs are monoclonal antibodies that target programmed death receptor 1 (PD-1), its ligand PD-L1, or CTLA-4. With ICI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f54e0e1fba8eb04f4b0078568221493
https://doi.org/10.1080/14737140.2022.2029414
https://doi.org/10.1080/14737140.2022.2029414
Autor:
Anu Amallraja, Tyler Gonser, Casey Williams, Melissa Hinrichsen, Rachel Elsey, Pradip De, Tobias Meissner, Kirstin Williams, Blake Buzard, Brian Leyland-Jones
Publikováno v:
Cancer Research. 79:5147-5147
Introduction: Despite many advances, the treatment for most patients with advanced solid tumors in the abdomen continues to be a clinical challenge. The purpose of our study was to evaluate the clinical benefit of molecularly-guided treatment strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::898c053781895a02dd6d006eca76bb83
https://doi.org/10.1158/1538-7445.am2019-5147
https://doi.org/10.1158/1538-7445.am2019-5147